BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19619258)

  • 41. Platelet Activation Assessed by Glycoprotein VI/Platelet Ratio Is Associated With Portal Vein Thrombosis After Hepatectomy and Splenectomy in Patients With Liver Cirrhosis.
    Matsui T; Usui M; Wada H; Iizawa Y; Kato H; Tanemura A; Murata Y; Kuriyama N; Kishiwada M; Mizuno S; Sakurai H; Isaji S
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):254-262. PubMed ID: 29050501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver transplantation in adult patients with portal vein thrombosis: risk factors, management and outcome.
    Lendoire J; Raffin G; Cejas N; Duek F; Barros Schelotto P; Trigo P; Quarin C; Garay V; Imventarza O
    HPB (Oxford); 2007; 9(5):352-6. PubMed ID: 18345318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study.
    Gao B; Xiao J; Zhang M; Zhang F; Zhang W; Yang J; He J; Liu Y; Zou X; Xu P; Zhuge Y
    Lipids Health Dis; 2019 Mar; 18(1):79. PubMed ID: 30927926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis.
    Villa E; Cammà C; Marietta M; Luongo M; Critelli R; Colopi S; Tata C; Zecchini R; Gitto S; Petta S; Lei B; Bernabucci V; Vukotic R; De Maria N; Schepis F; Karampatou A; Caporali C; Simoni L; Del Buono M; Zambotto B; Turola E; Fornaciari G; Schianchi S; Ferrari A; Valla D
    Gastroenterology; 2012 Nov; 143(5):1253-1260.e4. PubMed ID: 22819864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Portal vein flow rate used as a early predictor of portal vein thrombosis after periesophagastric devascularization].
    Zhang Y; Wen TF; Chen ZY; Yan LN; Liang GL; Li G; Zhang XH; Ran S; Liao ZX
    Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(11):825-8. PubMed ID: 19961011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The risk factors of portal vein thrombosis in patients with liver cirrhosis.
    Cagin YF; Bilgic Y; Berber İ; Yildirim O; Erdogan MA; Firat F; Arslan AK; Colak C; Seckin Y; Harputluoglu M
    Exp Ther Med; 2019 Apr; 17(4):3189-3194. PubMed ID: 30936992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Portal vein thrombosis in cirrhosis with variceal hemorrhage.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Gastrointest Surg; 1997; 1(2):123-30, discussion 130-1. PubMed ID: 9834338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Portal vein thrombosis in patients with hepatocellular carcinoma and early cirrhosis-prevalence and risk factors.
    Siddiqui MTU; Fareed G; Khan MR; Riaz A; Hamid SS
    Ecancermedicalscience; 2023; 17():1581. PubMed ID: 37533945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence and clinical presentation of portal vein thrombosis in cirrhotic patients.
    Cagin YF; Atayan Y; Erdogan MA; Dagtekin F; Colak C
    Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):499-503. PubMed ID: 27733319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of portal vein thrombosis in liver cirrhosis.
    Qi X; Han G; Fan D
    Nat Rev Gastroenterol Hepatol; 2014 Jul; 11(7):435-46. PubMed ID: 24686266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Portal vein thrombosis in liver cirrhosis - the added value of contrast enhanced ultrasonography.
    Danila M; Sporea I; Popescu A; Șirli R
    Med Ultrason; 2016 Jun; 18(2):218-33. PubMed ID: 27239658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Orthotopic liver transplantation in the presence of partial or total portal vein thrombosis: problems in diagnosis and management.
    Cherqui D; Duvoux C; Rahmouni A; Rotman N; Dhumeaux D; Julien M; Fagniez PL
    World J Surg; 1993; 17(5):669-74. PubMed ID: 8273391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
    Loffredo L; Pastori D; Farcomeni A; Violi F
    Gastroenterology; 2017 Aug; 153(2):480-487.e1. PubMed ID: 28479379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Portal vein thrombosis in patients with cirrhosis: just a common finding or a predictor of poor outcome?
    Borjas-Almaguer OD; Cortez-Hernández CA; González-Moreno EI; Bosques-Padilla FJ; González-González JA; Garza AA; Martínez-Segura JA; García-Compean D; Alejandre-Loya JV; García-García J; Delgado-García G; Maldonado-Garza HJ
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):902-906. PubMed ID: 27740524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis.
    Li MX; Zhang XF; Liu ZW; Lv Y
    Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):512-9. PubMed ID: 24103282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development.
    Zocco MA; Di Stasio E; De Cristofaro R; Novi M; Ainora ME; Ponziani F; Riccardi L; Lancellotti S; Santoliquido A; Flore R; Pompili M; Rapaccini GL; Tondi P; Gasbarrini GB; Landolfi R; Gasbarrini A
    J Hepatol; 2009 Oct; 51(4):682-9. PubMed ID: 19464747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis.
    Chen H; Liu L; Qi X; He C; Wu F; Fan D; Han G
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):82-9. PubMed ID: 26513611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation.
    Zanetto A; Campello E; Spiezia L; Gavasso S; Bulato C; Burra P; Russo FP; Senzolo M; Simioni P
    Dig Liver Dis; 2024 Jun; ():. PubMed ID: 38834381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.